<DOC>
	<DOCNO>NCT02502721</DOCNO>
	<brief_summary>A randomized , open-labeled , oral dose , crossover design clinical trial evaluate pharmacokinetics safety DWC20151 DWC20152 healthy male subject .</brief_summary>
	<brief_title>A Clinical Trial Evaluate Pharmacokinetics Safety Between DWC20151 DWC20152</brief_title>
	<detailed_description>This study evaluate pharmacokinetics safety DWC20151 DWC20152 healthy male subject . Study design randomize , open-labeled , oral dose , crossover design . This study conduct 2 separated part ( Part A , Part B ) .</detailed_description>
	<criteria>Healthy male subject ( 18~55 year ) Who allergy investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Male</keyword>
</DOC>